Navigation Links
KaloBios Announces Retirement Of Chief Financial Officer
Date:8/5/2013

generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

Forward Looking Statements
This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's clinical development of KB001-A, KB003 and KB004. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the company's limited cash reserves and its ability to obtain additional capital on acceptable terms, or at all, including the additional capital which will be necessary to complete the clinical trials that the company has initiated or plans to initiate; the company's dependence on Sanofi Pasteur for the development and commercialization of KB001-A; the company's ability to successfully complete further development of its programs; the uncertainties inherent in clinical testing; the timing, cost and uncertainty of obtaining regulatory approvals; the company's ability to protect the company's intellectual property; competition; changes in the regulatory landscape or the imposition of regulations that affect the company's products; the company's ability to attract and retain key personnel; and other factors l
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
2. U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios Novel Biologic Candidate for Pseudomonas aeruginosa
3. KaloBios Announces Fiscal Year 2012 Financial Results
4. Natural Acne Treatment, Probiotic Action Announces Their Topical Probiotic Is Safe for Sun Exposure
5. Sorrento Therapeutics Announces Reverse Split of Common Stock
6. SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER FINANCIAL RESULTS
7. Visiting Nurse Association of Northern New Jersey Announces Gardening Program at Friendship House Adult Day Care
8. Metabolix Announces Second Quarter 2013 Financial Results
9. Life Technologies Announces Second Quarter 2013 Results
10. BioAstrum Announces New Transfection Tools Market Report
11. MiMedx Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 A major challenge before ... start-up dense realm of Boston-Cambridge, is gaining visibility that ... James Sherley, the Director of Boston’s Adult Stem Cell ... and national visibility of his company an important priority ... In addition to a social media marketing campaign ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency ... to 150 ppb,” said Mark Tess, PhD, Mycotoxin Product Manager ... plant owners and USDA-GIPSA inspection agencies that have a need ... take place in a matter of minutes with nothing but ... the feed and grain before accepting it, but they no ...
(Date:8/28/2014)... Aug. 28, 2014  Next month, executives from clinical trial ... industry events beginning with Patient-Centered Clinical Trials 2014 , ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits of ... of tactics – from media to mobile apps – can ...
(Date:8/28/2014)... USA (PRWEB) August 27, 2014 Scientists, ... month for SPIE Laser Damage 2014 symposium. ... materials for high-power lasers will run 14-17 September. The ... for optics and photonics . , The premier conference ... understanding laser damage to optical materials will engage researchers ...
Breaking Biology Technology:The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3
... Wauwatosa, Wis. - William R. Hendee will retire effective ... Sciences at the Medical College of Wisconsin , and ... ,Hendee, who also will retire as president of the MCW ... Medical College conducts a national search for a permanent successor ...
... Waukesha, Wis. - A new remotely hosted technology released ... at a Texas hospital, and some rural Wisconsin healthcare facilities ... with a hosted model. , ,GE's new remote hosting product, ... comprehensive medical record interoperability, and do so more affordably. The ...
... Inc. , a Madison company that develops and markets molecular ... Kay Napier to its board of directors. , ,Napier's background ... Third Wave, according to president and CEO Kevin T. Conroy. ... the promotion of products at Procter & Gamble ...
Cached Biology Technology:Medical College grad school dean Bill Hendee to retire 2GE introduces remotely hosted health services 2GE introduces remotely hosted health services 3GE introduces remotely hosted health services 4Napier joins board of Third Wave Technologies 2
(Date:8/28/2014)... from Washington, Oregon, northern California, and Alaska totaled 515 ... of 2014, an increase of more than 10 percent ... Forest Service,s Pacific Northwest Research Station reported today. During ... 4 percent to 247 million board feet. , The ... than 5 percent to $390 million in the same ...
(Date:8/27/2014)... , Aug. 27, 2014  WaferGen Bio-systems, Inc. ... previously announced underwritten public offering of units of common ... unit for gross proceeds of $20 million, prior to ... by the Company.  The shares and warrants are immediately ... Each unit sold in the offering consists of 2,000 ...
(Date:8/27/2014)... -- Duke University researchers have identified a gene that ... OSCA1, encodes a protein in the cell membrane of ... the plant,s water conservation machinery accordingly. , "It,s ... professor of biology at Duke. , The findings, ... , could make it easier to feed the world,s ...
Breaking Biology News(10 mins):West coast log exports up, lumber exports down in second quarter of 2014 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3Water 'thermostat' could help engineer drought-resistant crops 2
... biology scientists from diverse areas of research are developing ... and derive therapeutic targets from biological networks, reports Genetic ... of much of the work is to characterize the ... biological networks, according to an article in the October ...
... the University of Leicester has addressed an international conference ... for monitoring the rainforests. Professor Heiko Balzter told ... radar satellites for monitoring tropical deforestation and forest biomass". ... and Europe had come together for the 8th Seminar ...
... caused by a newly described species of bacteria that ... help improve the diagnosis and treatment of similar infections, ... of the International Journal of Systematic and Evolutionary ... patients susceptible to infections with Mycobacterium species, the bacteria ...
Cached Biology News:University of Leicester professor adds new perspective to rainforest debate 2Scientists discover bacteria that can cause bone infections 2
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Sheep polyclonal to Salmonella Thomasville ( Abpromise for all tested applications). Antigen: Native Salmonella thomasville...
... to Oct6 ( Abpromise for all tested ... conjugated to KLH derived from within residues 1 ... amino acid sequence is proprietary) ... Entrez Gene ID: 5453 ...
Mouse monoclonal [X223] to Lamin B1 + B2 - Nuclear Envelope Marker ( Abpromise for all tested applications). entrezGeneID: 4001 SwissProtID: P20700...
Biology Products: